Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia
出版年份 2017 全文链接
标题
Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia
作者
关键词
-
出版物
NATURE MEDICINE
Volume 23, Issue 4, Pages 472-482
出版商
Springer Nature
发表日期
2017-03-20
DOI
10.1038/nm.4310
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
- (2015) Seyedmehdi Shojaee et al. CANCER CELL
- Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells
- (2015) Robert S. Welner et al. CANCER CELL
- Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure
- (2015) R. Pagliarini et al. EMBO REPORTS
- RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer
- (2015) Gorjan Hrustanovic et al. NATURE MEDICINE
- BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis
- (2015) Frederik Otzen Bagger et al. NUCLEIC ACIDS RESEARCH
- Targeting substrate-site in Jak2 kinase prevents emergence of genetic resistance
- (2015) Meenu Kesarwani et al. Scientific Reports
- Tristetraprolin (TTP): Interactions with mRNA and proteins, and current thoughts on mechanisms of action
- (2013) Seth A. Brooks et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
- (2013) D. M. Ross et al. BLOOD
- Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation, and survival
- (2012) K. H. Chang et al. BLOOD
- NetWalker: a contextual network analysis tool for functional genomics
- (2012) Kakajan Komurov et al. BMC GENOMICS
- Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib
- (2012) Ling Li et al. CANCER CELL
- Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
- (2012) Kathryn G. Roberts et al. CANCER CELL
- Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia
- (2012) Bin Zhang et al. CANCER CELL
- Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions
- (2012) Ahmed Lawan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development
- (2011) Damien Reynaud et al. CANCER CELL
- Exploiting the balance between life and death: Targeted cancer therapy and “oncogenic shock”
- (2010) Sreenath V. Sharma et al. BIOCHEMICAL PHARMACOLOGY
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
- (2010) Amie S. Corbin et al. JOURNAL OF CLINICAL INVESTIGATION
- Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
- (2010) François-Xavier Mahon et al. LANCET ONCOLOGY
- Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
- (2009) Chen Zhao et al. NATURE
- Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages
- (2009) Gabriela Molina et al. Nature Chemical Biology
- Shifting paradigms: the seeds of oncogene addiction
- (2009) Charles L Sawyers NATURE MEDICINE
- Fluorocurcumins as Cyclooxygenase-2 Inhibitor: Molecular Docking, Pharmacokinetics and Tissue Distribution in Mice
- (2009) Subhash Padhye et al. PHARMACEUTICAL RESEARCH
- Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy
- (2008) D Bruennert et al. LEUKEMIA
- Activation of tyrosine kinases by mutation of the gatekeeper threonine
- (2008) Mohammad Azam et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer
- (2008) T. Boutros et al. PHARMACOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More